IPOs surge for biotech companies in Q2

IPOThe National Venture Capital Association reports that IPOs in the biotechnology space during the second quarter of 2013 reached a 13-year high.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.